Ausgabe 1/2012
Inhalt (12 Artikel)
Lessons from ALL-REZ BFM 90: Therapy for Childhood Leukemia Based on Timing and Site of Relapse
- Invited Commentary
Michael E. Rytting
Can Prognostic Factors Be Used to Direct Therapy in Chronic Lymphocytic Leukemia?
- Chronic Lymphocytic Leukemia (S O'Brien, Section Editor)
Leopold Sellner, Sascha Dietrich, Peter Dreger, Hanno Glimm, Thorsten Zenz
Immune Reconstitution in Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia (S O'Brien, Section Editor)
John C. Riches, Alan G. Ramsay, John G. Gribben
Treatment of Older Patients with Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia (S O'Brien, Section Editor)
Nicole Lamanna
Inhibiting B-Cell Receptor Signaling Pathways in Chronic Lymphocytic Leukemia
- Chronic Lymphocytic Leukemia (S O’Brien, Section Editor)
Jan A. Burger
Disordered Epigenetic Regulation in the Pathophysiology of Myeloproliferative Neoplasms
- Myeloproliferative Neoplasms (JJ Kiladjian, Section Editor)
Su-Jiang Zhang, Omar Abdel-Wahab
Prognostication in Primary Myelofibrosis
- Myeloproliferative Neoplasms (JJ Kiladjian, Section Editor)
Francisco Cervantes, Arturo Pereira
Management of Myeloproliferative Neoplasms: From Academic Guidelines to Clinical Practice
- Myeloproliferative Neoplasms (JJ Kiladjian, Section Editor)
Giovanni Barosi, Letizia Lupo, Vittorio Rosti
Role of TET2 Mutations in Myeloproliferative Neoplasms
- Myeloproliferative Neoplasms (JJ Kiladjian, Section Editor)
Elodie Pronier, François Delhommeau
What Happened to Anti-CD33 Therapy for Acute Myeloid Leukemia?
- Acute Myelogenous Leukemia (EJ Feldman, Section Editor)
Joseph G. Jurcic
Management of Refractory Acute Myeloid Leukemia: Re-induction Therapy or Straight to Transplantation?
- Acute Myelogenous Leukemia (EJ Feldman, Section Editor)
E. J. Feldman, Usama Gergis
Transformation of a Chronic Myeloproliferative Neoplasm to Acute Myelogenous Leukemia: Does Anything Work?
- Acute Myelogenous Leukemia (EJ Feldman, Section Editor)
Madappa N. Kundranda, Raoul Tibes, Ruben A. Mesa